Ticagrelor
CAS 274693-27-5
Overview
Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y12 receptor
Anant Labs manufacture and furnish high quality Ticagrelor impurities for global markets. Our Ticagrelor EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.







![Chemical structure of N-(3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo [4 ,5-d]pyrimidin-7-yl)-N-((1R,2S,3S,4S)-2,3-dihydroxy -4-(2-hydroxy ethoxy)cyclopentyl)nitrous amide](/molecules/ANT-TCG-38.png)







































